Atika Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,000
| Closed | -$6.09M | – | 111 |
|
|
2024
Q2 | $6.09M | Buy |
+13,000
| New | +$6.09M | 0.6% | 52 |
|
|
2020
Q2 | – | Sell |
-8,000
| Closed | -$1.9M | – | 103 |
|
|
2020
Q1 | $1.9M | Buy |
+8,000
| New | +$1.9M | 0.36% | 61 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 83 |
|
|
2019
Q2 | – | Sell |
-26,000
| Closed | -$4.78M | – | 88 |
|
|
2019
Q1 | $4.78M | Buy |
26,000
+5,500
| +27% | +$1.01M | 0.97% | 35 |
|
|
2018
Q4 | $3.4M | Buy |
20,500
+2,500
| +14% | +$414K | 1% | 32 |
|
|
2018
Q3 | $3.47M | Buy |
18,000
+6,000
| +50% | +$1.16M | 0.62% | 54 |
|
|
2018
Q2 | $2.04M | Sell |
12,000
-3,000
| -20% | -$510K | 0.39% | 60 |
|
|
2018
Q1 | $2.45M | Buy |
15,000
+3,000
| +25% | +$489K | 0.84% | 41 |
|
|
2017
Q4 | $1.8M | Buy |
+12,000
| New | +$1.8M | 0.7% | 50 |
|
|
2015
Q1 | – | Sell |
-9,500
| Closed | -$1.13M | – | 73 |
|
|
2014
Q4 | $1.13M | Sell |
9,500
-15,000
| -61% | -$1.78M | 0.83% | 44 |
|
|
2014
Q3 | $2.75M | Buy |
+24,500
| New | +$2.75M | 2.12% | 16 |
|